Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Operating Margin: 2020-2025

Historic Operating Margin for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Sep 2025 value amounting to 1.96%.

  • Mirum Pharmaceuticals' Operating Margin rose 1599.00% to 1.96% in Q3 2025 from the same period last year, while for Sep 2025 it was -8.86%, marking a year-over-year increase of 2240.00%. This contributed to the annual value of -26.00% for FY2024, which is 3256.00% up from last year.
  • Mirum Pharmaceuticals' Operating Margin amounted to 1.96% in Q3 2025, which was up 150.13% from -3.90% recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Operating Margin ranged from a high of 1,408.25% in Q1 2021 and a low of -1,452.36% during Q4 2021.
  • Over the past 3 years, Mirum Pharmaceuticals' median Operating Margin value was -31.12% (recorded in 2024), while the average stood at -33.95%.
  • Its Operating Margin has fluctuated over the past 5 years, first crashed by 1,248,251bps in 2021, then skyrocketed by 132,994bps in 2022.
  • Mirum Pharmaceuticals' Operating Margin (Quarterly) stood at -1,452.36% in 2021, then skyrocketed by 132,994bps to -122.41% in 2022, then skyrocketed by 7,557bps to -46.85% in 2023, then skyrocketed by 2,248bps to -24.36% in 2024, then skyrocketed by 1,599bps to 1.96% in 2025.
  • Its last three reported values are 1.96% in Q3 2025, -3.90% for Q2 2025, and -13.61% during Q1 2025.